- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GeneDx Holdings Corp (WGS)
The GeneDx Holdings share price today is 82.23, view NASDAQ WGS stock exchange data. Track the latest GeneDx Holdings share price with real-time updates on WGS stock performance including market cap, day range, 52-week range and dividend yield. Access WGS charts, earnings dates and analyst estimates to support your investment decisions.
82.23
+0.49(+0.60%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
81.74
83.87
52 wk Range
32.21
170.87
WGS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
81.7483.87
52 wk Range
32.21170.87
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
WGS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
90.44
Upside
+9.99%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 90.44
(+9.99% Upside)
GeneDx Holdings Corp Earnings Call Summary for Q2/2026
- GeneDx Q2 revenue hit $114.4M, beating forecasts by 3.05%; achieved adjusted net income of $0.4M one quarter ahead of plan despite EPS miss of $0.28.
- Exome and genome test volume surged 32% YoY to record 30,785 tests; gross margin improved to 70% after completing $25M in annual cost reductions.
- Shares jumped 15.1% to $75 in after-hours trading on strong volume growth and earlier-than-expected profitability milestone.
- Company reaffirmed 2026 guidance of $475M-$490M revenue with 30%+ volume growth; Q3 revenue expected at $122M-$124M with ~$2M adjusted net income.
- Management prioritizes revenue cycle improvements to boost collection rates toward 70% industry standard, with biggest gains expected in 2027 from payer coverage.
Last Updated: 04-08-2026, 03:10 am
Read Full TranscriptEarnings
Latest Release
03-08-2026
EPS / Forecast
-0.28 / -0.14
Revenue / Forecast
114.4M / 111.01M
Compare WGS to Peers and Sector
Metrics to compare | WGS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWGSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −23.1x | −43.3x | −0.4x | |
PEG Ratio | 0.00 | 0.53 | 0.00 | |
Price/Book | 10.0x | 2.8x | 2.6x | |
Price / LTM Sales | 5.4x | 1.5x | 3.1x | |
Upside (Analyst Target) | 10.1% | 19.4% | 47.5% | |
Fair Value Upside | Unlock | −6.8% | 5.9% | Unlock |
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the GeneDx Holdings (WGS) Share Price Today?
The GeneDx Holdings share price today is 82.23.
What is the current GeneDx Holdings (WGS) share price and day range?
As of 12-08-2026, the GeneDx Holdings share price is 82.23, with a previous close of 81.74. The share price has ranged from 81.74 to 83.87 today, while the 52-week range spans from 32.21 to 170.87.
What Is the GeneDx Holdings Market Cap?
As of today, GeneDx Holdings market cap is 2.46B.
What Is the GeneDx Holdings (WGS) Share Price Target?
The average 12-month share price target for GeneDx Holdings is 90.44, with a high estimate of 103 and a low estimate of 74. 9 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +9.99% Upside potential.
What Is GeneDx Holdings's Earnings Per Share (TTM)?
The GeneDx Holdings EPS (TTM) is -3.64.
When Is the Next GeneDx Holdings Earnings Date?
GeneDx Holdings will release its next earnings report on 03-11-2026.
From a Technical Analysis Perspective, Is WGS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does GeneDx Holdings Trade On?
GeneDx Holdings is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for GeneDx Holdings?
The stock symbol for GeneDx Holdings is "WGS."
How Many Times Has GeneDx Holdings Stock Split?
GeneDx Holdings has split 1 times.
How Many Employees Does GeneDx Holdings Have?
GeneDx Holdings has 1300 employees.
What Is the WGS Premarket Price?
WGS's last pre-market stock price is 83.24. The pre-market share volume is 860.00, and the stock has changed by 1.50, or 1.84%.
What Is the WGS After Hours Price?
WGS's last after hours stock price is 81.98, the stock has changed by 0.24, or 0.29%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.